New patent expiration for Takeda Pharms drug DEXILANT
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two […]
New patent expiration for Takeda Pharms drug DEXILANT Read Post »
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two […]
New patent expiration for Takeda Pharms drug DEXILANT Read Post »
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in
New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB Read Post »
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA.
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 8,722,084 Expiration: Apr 15, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of April 14, 2024 Read Post »
DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 8,784,885 Expiration: Apr 15, 2024 See More … For more information on how
Drug Patent Expirations for the Week of April 14, 2024 Read Post »
Annual Drug Patent Expirations for MAVENCLAD Mavenclad is a drug marketed by Emd Serono Inc and is included in one
New patent expiration for Emd Serono drug MAVENCLAD Read Post »
Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in
New patent expiration for Mylan Speciality drug TOBI PODHALER Read Post »
Annual Drug Patent Expirations for RELISTOR Relistor is a drug marketed by Salix Pharms and Salix and is included in
New patent expiration for Salix Pharms drug RELISTOR Read Post »
Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one
New patent expiration for Insmed Inc drug ARIKAYCE KIT Read Post »
Get fresh news and insights, drug patent expirations & more…